newsfilter
← Latest News
Business Wire·

Quince Therapeutics Settles Approximately $16.4 Million of Debt

Quince Therapeutics, Inc. (NASDAQ:QNCX) today announced the successful settlement of the company's outstanding obligations under its loan from the European Investment Bank (EIB) for a payment of $5.5 million. This marks